Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Lymphoma; Lymphoma, Follicular | Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin | Phase 3 | ClinicalTrials |
| Multiple Myeloma; Neoplasms, Plasma Cell | Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid | Phase 1 | ClinicalTrials |
| Lymphoma; Lymphoma, Mantle-Cell | Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin | Phase 1 | ClinicalTrials |
| Lymphoma | Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, Non-Hodgkin | Phase 1 | ClinicalTrials |
| Lymphoma; Lymphoma, Non-Hodgkin | Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, Non-Hodgkin | Phase 1 | ClinicalTrials |
| Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin | Phase 1/Phase 2 | ClinicalTrials |
CONTENTS